ArticleJournal of virus eradication2016
HIV/AIDS in the South-East Asia region: progress and challenges.
Article in Journal of virus eradication, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Progressing towards the 2030 health-related SDGs in ASEAN: A systematic analysis.PLoS medicine · 2025Pooled it
- The burden of HIV/AIDS among children and adolescents under 20 years of age in China and ASEAN countries from 1990 to 2023 and projections of future trends.European journal of pediatrics · 2026Article
- An update on bloodborne viruses among people who inject drugs in South Asia.Harm reduction journal · 2026Review
- Sexual risk behaviours and population size estimation of men who have sex with men in Bhutan: a cross-sectional survey.BMJ public health · 2026Article
- Health-related quality of life in children with HIV/AIDS: Child and parent perspectives at a tertiary ART clinic in Kathmandu, Nepal.PloS one · 2026Article
- From criminalization to care: a comparative rights-based policy review of HIV responses in South Asia.Frontiers in public health · 2025Review
- Identification of cytokine signatures in HIV‑infected individuals with and withoutBiomedical reports · 2024Article
- The Impact of an Educational Program on Cervical Cancer Knowledge Among HIV-Positive Women in Bali, Indonesia.International journal of women's health · 2024Article
- Article
- The Influence of Anticipated HIV Stigma on Health-related Behaviors, Self-rated Health, and Treatment Preferences Among People Living with HIV in East Asia.AIDS and behavior · 2023Article
- Application of the network scale-up method to estimate the sizes of key populations for HIV in Singapore using online surveys.Journal of the International AIDS Society · 2023Article
- Article
- Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study.The Lancet regional health. Western Pacific · 2023Article
- Potential roles of pharmacists in HIV/AIDS care delivery in Nepal: A qualitative study.PloS one · 2023Article
- Health Care Needs Among People Living with HIV: The Implication of Continuum of Care.HIV/AIDS (Auckland, N.Z.) · 2023Article
- Stigma as a barrier and sex work as a protective factor for HIV testing among trans women in Nepal.PLOS global public health · 2023Article
- Article
- Socioeconomic inequalities in the HIV testing during antenatal care: evidence from Indian demographic health survey, 2015-16.BMC public health · 2022Article
- Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.The lancet. HIV · 2021Article
- Antiretroviral therapy (ART) coverage at public and private ART facilities in Myanmar.AIDS care · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The South-East Asia region, with 11 member states, has an estimated 3.5 million people living with HIV (PLHIV). More than 99% of PLHIV live in five countries where HIV prevalence among the population aged 15-49 remains low but is between 2% and 29% among key populations. Since 2010, the region has made progress to combat the epidemic. Mature condom programmes exist in most countries but opioid substitution therapy, and needle and syringe exchange programmes need to be scaled up. HIV testing is recommended nationwide in four countries and is prioritised in high prevalence areas or for key populations in the rest. In 2015, PLHIV aware of their HIV status ranged from 26% to 89%. Antiretroviral therapy (ART) is recommended for all PLHIV in Thailand and Maldives while six countries recommend ART at CD4 cell counts <500 cells/mm3. In 2015, 1.4 million (39%) PLHIV were receiving ART compared to 670,000 (20%) in 2010. Coverage of HIV testing and treatment among HIV-positive pregnant women has also improved but remains low in all countries except Thailand, which has eliminated mother-to-child transmission of HIV and syphilis. Between 2010 and 2015, AIDS-related deaths and new HIV infections have shown a declining trend in all the high-burden countries except Indonesia. But the region is far from achieving the 90-90-90 target by 2020 and the end of AIDS by 2030. The future HIV response requires that governments work in close collaboration with communities, address stigma and discrimination, and efficiently invest domestic resources in evidence-based HIV testing and treatment interventions for populations in locations that need them most.
Indexed as
Identifiers
28303199PMC5353351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.